AT328447B - Verfahren zur herstellung neuer 1,4-dihydropyridine - Google Patents

Verfahren zur herstellung neuer 1,4-dihydropyridine

Info

Publication number
AT328447B
AT328447B AT507473A AT507473A AT328447B AT 328447 B AT328447 B AT 328447B AT 507473 A AT507473 A AT 507473A AT 507473 A AT507473 A AT 507473A AT 328447 B AT328447 B AT 328447B
Authority
AT
Austria
Prior art keywords
dihydropyridine
preparing new
preparing
new
Prior art date
Application number
AT507473A
Other languages
English (en)
Other versions
ATA507473A (de
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Priority to AT177175A priority Critical patent/AT332405B/de
Publication of ATA507473A publication Critical patent/ATA507473A/de
Application granted granted Critical
Publication of AT328447B publication Critical patent/AT328447B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT507473A 1972-06-10 1973-06-08 Verfahren zur herstellung neuer 1,4-dihydropyridine AT328447B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT177175A AT332405B (de) 1972-06-10 1975-03-07 Verfahren zur herstellung neuer 1,4-dihydropyridine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2228363A DE2228363A1 (de) 1972-06-10 1972-06-10 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ATA507473A ATA507473A (de) 1975-06-15
AT328447B true AT328447B (de) 1976-03-25

Family

ID=5847399

Family Applications (2)

Application Number Title Priority Date Filing Date
AT177075*7A AT329561B (de) 1972-06-10 1973-06-08 Verfahren zur herstellung neuer 1,4-dihydropyridine
AT507473A AT328447B (de) 1972-06-10 1973-06-08 Verfahren zur herstellung neuer 1,4-dihydropyridine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT177075*7A AT329561B (de) 1972-06-10 1973-06-08 Verfahren zur herstellung neuer 1,4-dihydropyridine

Country Status (19)

Country Link
US (1) US3923818A (de)
JP (1) JPS4948680A (de)
AT (2) AT329561B (de)
AU (1) AU473996B2 (de)
BE (1) BE800679A (de)
CA (1) CA999592A (de)
CH (7) CH589629A5 (de)
CS (5) CS178898B2 (de)
DD (1) DD109383A5 (de)
DE (1) DE2228363A1 (de)
ES (5) ES415749A1 (de)
FR (1) FR2187347B1 (de)
GB (1) GB1425059A (de)
HU (1) HU166354B (de)
IE (1) IE37773B1 (de)
IL (1) IL42458A (de)
NL (1) NL7308059A (de)
SU (5) SU511856A3 (de)
ZA (1) ZA733880B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981882A (en) * 1972-08-31 1976-09-21 Bayer Aktiengesellschaft Process for preparing 4-aryl of hetero-6-amino-3,4-dihydropyrid-2-one-3,5-dicarboxylic acid ester
US3971796A (en) * 1973-07-12 1976-07-27 Bayer Aktiengesellschaft 1,4-Dihydropyridine esters
US4466972A (en) * 1977-06-20 1984-08-21 Sandoz Ltd. Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4252956A (en) * 1979-03-19 1981-02-24 Vigante Brigita A Derivatives of 1,4-dihydropyridine-3-carbothiol acids
GB2111978B (en) * 1981-10-19 1985-05-01 Maruko Pharmaceutical Co 1 4-dihydropyridine compounds
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
JPS60210640A (ja) * 1984-10-05 1985-10-23 Hitachi Chem Co Ltd 積層板の製造法
GB8503429D0 (en) * 1985-02-11 1985-03-13 Ici Plc Chemical compounds
GB8503428D0 (en) * 1985-02-11 1985-03-13 Ici Plc Nitrogen-containing compounds
GB8503425D0 (en) * 1985-02-11 1985-03-13 Ici Plc Alkanolamine derivatives
GB8503427D0 (en) * 1985-02-11 1985-03-13 Ici Plc Basic compounds
US4593033A (en) * 1985-04-24 1986-06-03 Merck & Co., Inc. Substituted indeno[2,1-c] pyridines useful as calcium channel blockers
US4605660A (en) * 1985-06-03 1986-08-12 Merck & Co., Inc. Indeno[2,1-c]pyridine compounds, and their use as calcium channel blockers
US4670443A (en) * 1985-07-02 1987-06-02 Merck & Co., Inc. Benzo(f)isoquinoline compounds useful as calcium entry blockers
NL192385C (nl) * 1985-08-21 1997-07-04 Glaxo Spa 6-alkyl-4-fenyl-1,4-dihydro-3,5-pyridinecarbonzuuresters, werkwijze voor de bereiding daarvan en farmaceutische preparaten die deze esters bevatten.
DE3675747D1 (de) * 1985-08-21 1991-01-03 Glaxo Spa 1,4-dihydropyridinverbindungen und ihre herstellung und pharmazeutische formulierung.
US4735956A (en) * 1985-09-13 1988-04-05 Merck & Co., Inc. Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers
US4788203A (en) * 1985-11-26 1988-11-29 Merck & Co., Inc. Cyclized N-substituted-tetrahydropyridine compounds, useful in the treatment of cardiovascular disorders
US4721708A (en) * 1985-11-26 1988-01-26 Merck & Co., Inc. Cyclized N-substituted-tetrahydropyridine compounds and cardiovascular use
IT1204462B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
IT1204460B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
US5216172A (en) * 1988-02-24 1993-06-01 Ajinomoto Co., Inc. 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cells
EP0330470A3 (de) * 1988-02-24 1992-01-02 Ajinomoto Co., Inc. Gegen Tumorzellen verwendbare 1,4-Dihydropyridin-Derivate
FR2672890A1 (fr) * 1991-02-20 1992-08-21 Inst Investigacion Desarrol Derives de 2,6-dimethyl-4-(4'-hydroxy-3',5'-di-t-butylphenyl)-1,4-dihydropyridine, leur procede de preparation et leur utilisation comme capteurs de radicaux libres.
WO2000005209A1 (fr) * 1998-07-23 2000-02-03 Lin, Tong-Ho GUAIACOXYPROPANOLAMINES A ACTIVITE α/β-ADRENOLYTIQUE
EP1554572B1 (de) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US20030153773A1 (en) * 2002-02-14 2003-08-14 Wayne Gregory S. Process for the production of dihydropyridines
WO2005016885A2 (en) * 2003-08-14 2005-02-24 Artesian Therapeutics, Inc. COMPOUNDS WITH COMBINED CALCIUM CHANNEL BLOCKER AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITIES FOR TREATMENT OF HEART DISEASE
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2003146A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate

Also Published As

Publication number Publication date
ZA733880B (en) 1974-05-29
DD109383A5 (de) 1974-11-05
CH591443A5 (de) 1977-09-15
IE37773L (en) 1973-12-10
ATA177075A (de) 1975-08-15
IL42458A (en) 1977-07-31
CS178897B2 (en) 1977-10-31
DE2228363A1 (de) 1974-01-03
SU507234A3 (ru) 1976-03-15
ATA507473A (de) 1975-06-15
ES440620A1 (es) 1977-03-01
AU5672573A (en) 1974-12-12
IE37773B1 (en) 1977-10-12
CS178899B2 (en) 1977-10-31
CS178900B2 (en) 1977-10-31
SU512708A3 (ru) 1976-04-30
GB1425059A (en) 1976-02-18
BE800679A (fr) 1973-12-10
ES415749A1 (es) 1976-06-16
HU166354B (de) 1975-03-28
ES440622A1 (es) 1977-03-01
AT329561B (de) 1976-05-25
NL7308059A (de) 1973-12-12
ES440619A1 (es) 1977-03-01
CH589058A5 (de) 1977-06-30
ES440621A1 (es) 1977-03-01
US3923818A (en) 1975-12-02
CH589629A5 (de) 1977-07-15
CH591444A5 (de) 1977-09-15
AU473996B2 (en) 1976-07-08
CH588462A5 (de) 1977-06-15
CH593260A5 (de) 1977-11-30
CA999592A (en) 1976-11-09
JPS4948680A (de) 1974-05-11
IL42458A0 (en) 1973-08-29
FR2187347A1 (de) 1974-01-18
CS178888B2 (en) 1977-10-31
CS178898B2 (en) 1977-10-31
FR2187347B1 (de) 1977-09-09
SU511856A3 (ru) 1976-04-25
CH589628A5 (de) 1977-07-15
SU510997A3 (ru) 1976-04-15
SU509221A3 (ru) 1976-03-30

Similar Documents

Publication Publication Date Title
AT329561B (de) Verfahren zur herstellung neuer 1,4-dihydropyridine
DD110652A5 (de) Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkinylaminopropane
ATA588973A (de) Verfahren zur herstellung neuer phenoxypropanolamine
CH549596A (de) Verfahren zur herstellung neuer n(6)-aralkyl-adenosinderivate.
AT324309B (de) Verfahren zur herstellung neuer 2-aminoalkanoylaminobenzophenone
CH555798A (de) Verfahren zur herstellung neuer 1,1-diphenyl-2-nitropropanderivate.
AT329570B (de) Verfahren zur herstellung neuer chinazolinonderivate
AT326653B (de) Verfahren zur herstellung neuer 2-amino-4-h-pyrane
AT327414B (de) Verfahren zur herstellung neuer bis-piperazino-androstan-derivate
AT331255B (de) Verfahren zur herstellung neuer hexahydrotriazinonderivate
AT327881B (de) Verfahren zur herstellung neuer furanderivate
AT367067B (de) Verfahren zur herstellung neuer 11,11-alkyliden- steroide
ATA470873A (de) Verfahren zur herstellung neuer anhydro- furanosederivate
ATA177175A (de) Verfahren zur herstellung neuer 1,4-dihydropyridine
AT326120B (de) Verfahren zur herstellung neuer isoxazolidinderivate
ATA173876A (de) Verfahren zur herstellung neuer 2,3-dihydro- benzofuranon-2-derivate
AT327192B (de) Verfahren zur herstellung neuer 1-(dialkylphenyl-phenyl-pyridyl)-methyl-imidazole
AT332417B (de) Verfahren zur herstellung neuer 1,2,4- benztriazin -1,4-di-n- oxidderivate
AT323893B (de) Verfahren zur herstellung von 8-oxo-5-thia-1-azabicyclo (4,2,0) oct-2-en-verbindungen
AT340396B (de) Verfahren zur herstellung neuer substituierter chloracetanilide
AT331203B (de) Verfahren zur herstellung von 1,2-dichlorathan
AT335462B (de) Verfahren zur herstellung neuer 1-nitrosoharnstoffderivate
AT322542B (de) Verfahren zur herstellung neuer nitrofuranverbindungen
AT332386B (de) Verfahren zur herstellung neuer 2-(-phenyl-n-(r1, r2-aminoalkyl- oder -alkanoyl))-amino-(1,2,3,4,-tetrahydronaphthalin)
ATA217675A (de) Verfahren zur herstellung neuer phenoxypropanolamine

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee